Business, energy, technology, markets and global industry news from Business News Today

regenerative medicine

PharmaDeviceNews regenerative medicine
Auxilium Biotechnologies tests multi-product tissue manufacturing in microgravity
Pharma & Biotech

What Auxilium’s orbital kidney and liver bioprinting milestone means for regenerative medicine

Auxilium Biotechnologies bioprints kidney and liver tissues in orbit, advancing microgravity biofabrication while major clinical hurdles remain.

Read More
Representative image: Syntax Bio’s expanded Series A funding highlights growing investor interest in Cellgorithm-driven stem cell therapy for type 1 diabetes.
Pharma & Biotech

Syntax Bio funding boost puts pancreatic beta cell therapy closer to preclinical test

Find out how Syntax Bio’s expanded Series A could shape Cellgorithm-based beta cell therapy for type 1 diabetes.

Read More
Pharma & Biotech

How NewcelX Ltd. is pursuing durable islet graft survival in the race for a functional diabetes cure

How NewcelX Ltd. is advancing NCEL-101 toward a functional diabetes cure through durable islet graft survival and immune protection strategies.

Read More
Representative image: Scientists work inside an advanced iPSC biomanufacturing lab as FUJIFILM Cellular Dynamics’ Madison facility highlights growing demand for stem cell manufacturing, regenerative medicine infrastructure and cell therapy scale-up.
Pharma & Biotech

Can FUJIFILM’s Madison facility help solve the scale problem in stem cell manufacturing?

iPSC demand is rising fast. FUJIFILM’s Madison facility tests whether stem cell manufacturing can keep pace with pharma and cell therapy needs.

Read More
Representative image: Science-backed skincare research is moving closer to longevity science, as AV Laboratories highlights how IVF-inspired bioscience and regenerative medicine thinking could reshape the future of premium skin wellness.
Pharma & Biotech

Can IVF-inspired skincare move AVL beyond beauty marketing into longevity science?

Beauty wants biotech credibility. AVL’s IVF-inspired skincare push tests whether longevity science can reshape premium skincare.

Read More
Pharma & Biotech

Charles River and MEDIPOST deepen cell therapy testing push across APAC and North America

Cell therapy scale-up is not just a science problem. Charles River and MEDIPOST are targeting the GMP testing bottleneck.

Read More
Pharma & Biotech

Terumo BCT and Steminent push automation into the fragile world of stem cell manufacturing

MSC science is advancing faster than manufacturing can scale. Terumo BCT and Steminent are testing whether automation can close that gap.

Read More
Pharma & Biotech

Can Cellular Intelligence revive Novo Nordisk’s shelved Parkinson’s cell therapy programme?

Novo shelved the asset, but Cellular Intelligence sees a platform test. Parkinson’s cell therapy now faces its harder commercial trial.

Read More
Representative image of an orthopedic surgical team reviewing ACL reconstruction anatomy and knee imaging, illustrating CoreTissue BioEngineering’s CT-ACL001 tissue-regenerative ligament trial and its potential role in advancing anterior cruciate ligament repair.
Medical Devices & Diagnostics

CoreTissue BioEngineering pushes ACL device strategy beyond early safety testing

ACL surgery needs better graft choices. CoreTissue BioEngineering’s CT-ACL001 now faces the harder randomized test.

Read More
Pharma & Biotech

Cryo-Cell avoided a delisting scare for now, but investors still face a 2027 countdown

Cryo-Cell avoided immediate delisting pressure. The harder test is whether its cord blood banking model can repair the balance sheet by 2027.

Read More